Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2013, Article ID 367956, 5 pages
http://dx.doi.org/10.1155/2013/367956
Research Article

Expression of SET Protein in the Ovaries of Patients with Polycystic Ovary Syndrome

1The State Laboratory of Reproductive Medicine, Clinical Center of Reproductive Medicine, First Affiliated Hospital, Nanjing Medical University, Nanjing 210029, China
2Department of Obstetrics and Gynecology, Second Affiliated Hospital of Nanjing Medical University, Nanjing 210011, China
3The First Affiliated Hospital, Nanjing Medical University, China

Received 24 January 2013; Revised 23 April 2013; Accepted 9 May 2013

Academic Editor: Maria L. Dufau

Copyright © 2013 Xu Boqun et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. C. J. M. Fauser, “Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome,” Fertility and Sterility, vol. 81, no. 1, pp. 19–25, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. D. A. Ehrmann, “Polycystic ovary syndrome,” The New England Journal of Medicine, vol. 352, no. 12, pp. 1223–1277, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. V. L. Nelson, R. S. Legro, J. F. Strauss 3rd, and J. M. McAllister, “Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries,” Molecular Endocrinology, vol. 13, no. 6, pp. 946–957, 1999. View at Google Scholar · View at Scopus
  4. V. L. Nelson, K. N. Qin, R. L. Rosenfield et al., “The biochemical basis for increased Testosterone production in theca cells propagated from patients with polycystic ovary syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 12, pp. 5925–5933, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Nakajin and P. F. Hall, “Microsomal cytochrome P-450 from neonatal pig testis. Purification and properties of A C21 steroid side-chain cleavage system (17 alpha-hydroxylase-C17,20 lyase),” The Journal of Biological Chemistry, vol. 256, no. 8, pp. 3871–3876, 1981. View at Google Scholar · View at Scopus
  6. J. K. Wickenheisser, V. L. Nelson-DeGrave, and J. M. McAllister, “Dysregulation of cytochrome P450 17α-hydroxylase messenger ribonucleic acid stability in theca cells isolated from women with polycystic ovary syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 3, pp. 1720–1727, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. J. R. Wood, V. L. Nelson, C. Ho et al., “The molecular phenotype of polycystic ovary syndrome (PCOS) theca cells and new candidate PCOS genes defined by microarray analysis,” The Journal of Biological Chemistry, vol. 278, no. 29, pp. 26380–26390, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. F. Y. Diao, M. Xu, Y. Hu et al., “The molecular characteristics of polycystic ovary syndrome (PCOS) ovary defined by human ovary cDNA microarray,” Journal of Molecular Endocrinology, vol. 33, no. 1, pp. 59–72, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Von Lindern, S. Van Baal, J. Wiegant, A. Raap, A. Hagemeijer, and G. Grosveld, “can, a putative oncogene associated with myeloid leukemogenesis, may be activated by fusion of its 3' half to different genes: characterization of the set gene,” Molecular and Cellular Biology, vol. 12, no. 8, pp. 3346–3355, 1992. View at Google Scholar · View at Scopus
  10. K. Nagata, H. Kawase, H. Handa et al., “Replication factor encoded by a putative oncogene, set, associated with myeloid leukemogenesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 10, pp. 4279–4283, 1995. View at Google Scholar · View at Scopus
  11. K. Nagata, S. Saito, M. Okuwaki et al., “Cellular localization and expression of template-activating factor I in different cell types,” Experimental Cell Research, vol. 240, no. 2, pp. 274–281, 1998. View at Publisher · View at Google Scholar · View at Scopus
  12. Z. Karetsou, G. Martic, G. Sflomos, and T. Papamarcaki, “The histone chaperone SET/TAF-Iβ interacts functionally with the CREB-binding protein,” Biochemical and Biophysical Research Communications, vol. 335, no. 2, pp. 322–327, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Li, A. Makkinje, and Z. Damuni, “The myeloid leukemia-associated protein SET is a potent inhibitor of protein phosphatase 2A,” The Journal of Biological Chemistry, vol. 271, no. 19, pp. 11059–11062, 1996. View at Publisher · View at Google Scholar · View at Scopus
  14. S. B. Seo, P. McNamara, S. Heo, A. Turner, W. S. Lane, and D. Chakravarti, “Regulation of histone acetylation and transcription by INHAT, a human cellular complex containing the set oncoprotein,” Cell, vol. 104, no. 1, pp. 119–130, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Zhang, N. A. Compagnone, C. Fiore et al., “Developmental gonadal expression of the transcription factor set and its target gene, P450c17 (17α-hydroxylase/c17,20 lyase),” DNA and Cell Biology, vol. 20, no. 10, pp. 613–624, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. N. A. Compagnone, P. Zhang, J. L. Vigne, and S. H. Mellon, “Novel role for the nuclear phosphoprotein SET in transcriptional activation of P450c17 and initiation of neurosteroidogenesis,” Molecular Endocrinology, vol. 14, no. 6, pp. 875–888, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Wagner, S. Weber, M. A. Kleinschmidt, K. Nagata, and U. M. Bauer, “SET-mediated promoter hypoacetylation is a prerequisite for coactivation of the estrogen-responsive pS2 gene by PRMT1,” The Journal of Biological Chemistry, vol. 281, no. 37, pp. 27242–27250, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Zhang and S. H. Mellon, “Multiple orphan nuclear receptors converge to regulate rat P450c17 gene transcription: Novel mechanisms for orphan nuclear receptor action,” Molecular Endocrinology, vol. 11, no. 7, pp. 891–904, 1997. View at Publisher · View at Google Scholar · View at Scopus
  19. L. Arnaud, S. Chen, F. Liu et al., “Mechanism of inhibition of PP2A activity and abnormal hyperphosphorylation of tau by I2(PP2A)/SET,” FEBS Letters, vol. 585, no. 17, pp. 2653–2659, 2011. View at Google Scholar
  20. A. V. Pandey, S. H. Mellon, and W. L. Miller, “Protein phosphatase 2A and phosphoprotein SET regulate androgen production by P450c17,” The Journal of Biological Chemistry, vol. 278, no. 5, pp. 2837–2844, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Y. Chang, P. C. Jennings, J. Stewart, N. M. Verrills, and K. T. Jones, “Essential role of protein phosphatase 2A in metaphase II arrest and activation of mouse eggs shown by okadaic acid, dominant negative protein phosphatase 2A, and FTY720,” The Journal of Biological Chemistry, vol. 286, no. 16, pp. 14705–14712, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. R. Azziz, E. Carmina, D. Dewailly et al., “Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess society guideline,” Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 11, pp. 4237–4245, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. J. K. Wickenheisser, V. L. Nelson-DeGrave, and J. M. McAllister, “Human ovarian theca cells in culture,” Trends in endocrinology and metabolism: TEM, vol. 17, no. 2, pp. 65–71, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. J. K. Wickenheisser, P. G. Quinn, V. L. Nelson, R. S. Legro, J. F. Strauss, and J. M. Mcallister, “Differential activity of the cytochrome P450 17α-hydroxylase and steroidogenic acute regulatory protein gene promoters in normal and polycystic ovary syndrome theca cells,” Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 6, pp. 2304–2311, 2000. View at Publisher · View at Google Scholar · View at Scopus